Found 5 matching trials
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
PHASE2This study employs a 2-stage design that aims to evaluate the efficacy and ...
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
PHASE2The goal of this clinical trial is to evaluate the impact that ENV-101 has ...
Status
Active Not Recruiting
A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
PHASE1The purposes of this study are to:
1. evaluate potential interactions betw...
A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects
PHASE1The goal of this clinical trial is to learn about the potential effect of E...
A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2This is a Phase 2, randomized, placebo controlled, multi-center study in su...